Aims: To investigate pulse pressure(PP) as an independent predictor of coronary heart disease(CHD) risk. Methods and results: On the basis of a 10-year follow-up of 5389 men aged 35-65 at recruitment into PROCAM, we u...
详细信息
Aims: To investigate pulse pressure(PP) as an independent predictor of coronary heart disease(CHD) risk. Methods and results: On the basis of a 10-year follow-up of 5389 men aged 35-65 at recruitment into PROCAM, we used a proportional hazards model to calculate the effect of systolic blood pressure(SBP), diastolic blood pressure(DBP), and PP on CHD risk after correcting for age, high-density lipoprotein cholesterol, LDL cholesterol, triglycerides, smoking, diabetes, and family history of premature CHD. Increases of 10 mmHg in DBP, SBP, and PP were associated with an increased CHD hazard ratio(HR) of ~ 10% . When the group was divided into the age groups59 years, this relationship was seen in the age group 50-59 years for DBP, SBP, and PP and in men aged ≥ 60 for PP only(25% increase in HR). Overall, CHD risk in men with PP ≥ 70 mmHg was more three times that of men with PP60 years, and was also present in men who were normotensive at recruitment(SBP ≤ 160 mmHg, DBP ≤ 95 mmHg). Conclusion: In older European men, increased PP is an important independent determinant of coronary risk, even among those initially considered normotensive.
Patientswithsystemicsclerosis(SSc)developoftenacralulcers which are resistant to therapy and may result in gangrene and amputation. We investigated the effect s of iloprost infusion on the acral ulcers and necrosis in...
详细信息
Patientswithsystemicsclerosis(SSc)developoftenacralulcers which are resistant to therapy and may result in gangrene and amputation. We investigated the effect s of iloprost infusion on the acral ulcers and necrosis in patients with five pa tients with SSc and one with mixed connective tissue disease who had been previo usly treated with various modalities without improvement. All patients had Rayna ud phenomenon, acral ulcers and necrosis. Iloprost 25 μg per day was administer ed intravenously daily over six hours for ten consecutive days. Eight weeks late r all patients were treated with a second iloprost therapy cycle for five days. Two patients with severe ulceration received a third cycle until remission occur red. In all cases acral ulcers hea led com pletely and no patient relapsed durin g an observation period of 6 months.
暂无评论